{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:01:26Z","timestamp":1787580086784,"version":"build-2736575974"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2014\/01115-9"],"award-info":[{"award-number":["2014\/01115-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/24832-6"],"award-info":[{"award-number":["2017\/24832-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>PspA and pneumolysin are two important vaccine candidates, able to elicit protection in different models of pneumococcal infection. The high immunogenic potential of PspA, combined with a possible adjuvant effect of pneumolysin derivatives (due to their ability to interact with TLR-4) could greatly improve the immunogenicity and coverage of a protein-based pneumococcal vaccine. A chimeric protein including the N-terminal region of PspA in fusion with the pneumolysin derivative, PlD1, has been shown to induce high antibody levels against each protein, and protect mice against invasive challenge. The aim of the present study was to investigate the cellular response induced by such vaccine, and to evaluate protection in a murine model of lobar pneumococcal pneumonia. Pneumococcal pneumonia was induced in BALB\/c mice by nasal instillation of a high dose of a serotype 14 strain with low virulence. Airway inflammation was confirmed by total and differential cell counts in BAL and by histological analysis of the lungs, and bacterial loads were measured 7 days after challenge. Cytokine levels were determined in the bronchoalveolar fluid (BALF) of mice immunized with rPspA-PlD1 fusion after challenge, by flow cytometry and ELISA. After challenge, the mice developed lung inflammation with no invasion of other sites, as demonstrated by histological analysis. We detected significant production of TNF-\u03b1 and IL-6 in the BALF, which correlated with protection against pneumonia in the group immunized with rPspA-PlD1. In conclusion, we found that the rPspA-PlD1fusion is protective against pneumococcal pneumonia in mice, and protection is correlated with an early and controlled local inflammatory response. These results are in agreement with previous data demonstrating the efficacy of the fusion protein against pneumococcal sepsis and reinforce the potential of the rPspA-PlD1 protein chimera as a promising vaccine strategy to prevent pneumococcal disease.<\/jats:p>","DOI":"10.1371\/journal.pone.0277304","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T18:40:30Z","timestamp":1670438430000},"page":"e0277304","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["A fusion protein comprising pneumococcal surface protein A and a pneumolysin derivate confers protection in a murine model of pneumococcal pneumonia"],"prefix":"10.1371","volume":"17","author":[{"given":"Tanila Wood","family":"dos Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Almeida","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunia","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Aires","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Augusto Real","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana C. C.","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3818-3215","authenticated-orcid":true,"given":"Lucio F. C.","family":"Ferraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago Rojas","family":"Converso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7829-3435","authenticated-orcid":true,"given":"Michelle","family":"Darrieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,12,7]]},"reference":[{"issue":"11","key":"pone.0277304.ref001","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"C Troeger","year":"2018","journal-title":"The Lancet Infectious Diseases"},{"issue":"6","key":"pone.0277304.ref002","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0028-2018","article-title":"Pneumococcal Vaccines.","volume":"7","author":"DE Briles","year":"2019","journal-title":"Microbiol Spectr"},{"issue":"6","key":"pone.0277304.ref003","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1016\/S1473-3099(18)30660-1","article-title":"Making sense of differences in pneumococcal serotype replacement","volume":"19","author":"JA Lewnard","year":"2019","journal-title":"The Lancet Infectious Diseases"},{"issue":"1","key":"pone.0277304.ref004","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/14760584.2020.1711055","article-title":"The long search for a serotype independent pneumococcal vaccine","volume":"19","author":"TR Converso","year":"2020","journal-title":"Expert Rev Vaccines"},{"issue":"27","key":"pone.0277304.ref005","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1016\/j.vaccine.2021.04.068","article-title":"Protective role of PhtD and its amino and carboxyl fragments against pneumococcal sepsis","volume":"39","author":"GO Andre","year":"2021","journal-title":"Vaccine"},{"issue":"1","key":"pone.0277304.ref006","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.vaccine.2016.11.027","article-title":"Systemic immunization with rPotD reduces Streptococcus pneumoniae nasopharyngeal colonization in mice","volume":"35","author":"TR Converso","year":"2017","journal-title":"Vaccine"},{"issue":"2","key":"pone.0277304.ref007","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1128\/CVI.00692-14","article-title":"Evaluation of a vaccine formulation against Streptococcus pneumoniae based on choline-binding proteins","volume":"22","author":"EN Miyaji","year":"2015","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"pone.0277304.ref008","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1128\/IAI.01103-06","article-title":"Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae","volume":"75","author":"AD Ogunniyi","year":"2007","journal-title":"Infect Immun"},{"issue":"5","key":"pone.0277304.ref009","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1128\/IAI.01554-08","article-title":"Protection against Pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide","volume":"77","author":"YJ Lu","year":"2009","journal-title":"Infect Immun"},{"key":"pone.0277304.ref010","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fmicb.2017.00224","article-title":"Role of Streptococcus pneumoniae Proteins in Evasion of Complement-Mediated Immunity.","volume":"8","author":"GO Andre","year":"2017","journal-title":"Front Microbiol"},{"key":"pone.0277304.ref011","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.micpath.2015.08.008","article-title":"Combined effects of lactoferrin and lysozyme on Streptococcus pneumoniae killing","volume":"89","author":"GO Andre","year":"2015","journal-title":"Microb Pathog"},{"key":"pone.0277304.ref012","doi-asserted-by":"crossref","first-page":"593215","DOI":"10.3389\/fmicb.2020.593215","article-title":"Resistance Mechanisms to Antimicrobial Peptides in Gram-Positive Bacteria.","volume":"11","author":"L Assoni","year":"2020","journal-title":"Front Microbiol"},{"issue":"4","key":"pone.0277304.ref013","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1073\/pnas.0435928100","article-title":"Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection","volume":"100","author":"R Malley","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"pone.0277304.ref014","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2174\/156652408785747924","article-title":"Pneumolysin: a double-edged sword during the host-pathogen interaction","volume":"8","author":"HM Marriott","year":"2008","journal-title":"Curr Mol Med"},{"issue":"38","key":"pone.0277304.ref015","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.1016\/j.vaccine.2017.08.010","article-title":"A protein chimera including PspA in fusion with PotD is protective against invasive pneumococcal infection and reduces nasopharyngeal colonization in mice","volume":"35","author":"TR Converso","year":"2017","journal-title":"Vaccine"},{"issue":"12","key":"pone.0277304.ref016","doi-asserted-by":"crossref","first-page":"5930","DOI":"10.1128\/IAI.00940-07","article-title":"Fusion proteins containing family 1 and family 2 PspA fragments elicit protection against Streptococcus pneumoniae that correlates with antibody-mediated enhancement of complement deposition","volume":"75","author":"M Darrieux","year":"2007","journal-title":"Infect Immun"},{"issue":"3","key":"pone.0277304.ref017","doi-asserted-by":"crossref","first-page":"e59605","DOI":"10.1371\/journal.pone.0059605","article-title":"Characterization of protective immune responses induced by pneumococcal surface protein A in fusion with pneumolysin derivatives","volume":"8","author":"C Goulart","year":"2013","journal-title":"PloS one"},{"issue":"3","key":"pone.0277304.ref018","article-title":"A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Streptococcus pneumoniae Challenge","volume":"87","author":"WY Chan","year":"2019","journal-title":"Infect Immun"},{"issue":"33","key":"pone.0277304.ref019","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1016\/j.vaccine.2011.05.051","article-title":"A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae","volume":"29","author":"P Denoel","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"pone.0277304.ref020","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1086\/376571","article-title":"Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae","volume":"188","author":"DE Briles","year":"2003","journal-title":"J Infect Dis"},{"issue":"8","key":"pone.0277304.ref021","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.vaccine.2010.12.074","article-title":"Selection of family 1 PspA molecules capable of inducing broad-ranging cross-reactivity by complement deposition and opsonophagocytosis by murine peritoneal cells","volume":"29","author":"C Goulart","year":"2011","journal-title":"Vaccine"},{"issue":"8","key":"pone.0277304.ref022","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1590\/S0100-879X2004000800001","article-title":"A high-copy T7 Escherichia coli expression vector for the production of recombinant proteins with a minimal N-terminal His-tagged fusion peptide","volume":"37","author":"CR Ramos","year":"2004","journal-title":"Braz J Med Biol Res"},{"issue":"5","key":"pone.0277304.ref023","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1128\/iai.63.5.1969-1974.1995","article-title":"Effect of defined point mutations in the pneumolysin gene on the virulence of Streptococcus pneumoniae","volume":"63","author":"AM Berry","year":"1995","journal-title":"Infect Immun"},{"issue":"10","key":"pone.0277304.ref024","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1128\/IAI.68.10.5889-5900.2000","article-title":"Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae","volume":"68","author":"SK Hollingshead","year":"2000","journal-title":"Infect Immun"},{"issue":"7","key":"pone.0277304.ref025","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/infdis\/jit502","article-title":"Broadly protective protein-based pneumococcal vaccine composed of pneumolysin toxoid-CbpA peptide recombinant fusion protein","volume":"209","author":"B Mann","year":"2014","journal-title":"J Infect Dis"},{"issue":"8","key":"pone.0277304.ref026","doi-asserted-by":"crossref","first-page":"e0273017","DOI":"10.1371\/journal.pone.0273017","article-title":"Immune response induced in mice by a hybrid rPotD-PdT pneumococcal protein.","volume":"17","author":"T Rojas Converso","year":"2022","journal-title":"PloS one"},{"issue":"1","key":"pone.0277304.ref027","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/IAI.68.1.133-140.2000","article-title":"Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins","volume":"68","author":"AM Berry","year":"2000","journal-title":"Infect Immun"},{"issue":"9","key":"pone.0277304.ref028","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1128\/CVI.00171-12","article-title":"Controlled inflammatory responses in the lungs are associated with protection elicited by a pneumococcal surface protein A-based vaccine against a lethal respiratory challenge with Streptococcus pneumoniae in mice","volume":"19","author":"FA Lima","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"8","key":"pone.0277304.ref029","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.vaccine.2015.01.014","article-title":"Trivalent pneumococcal protein recombinant vaccine protects against lethal Streptococcus pneumoniae pneumonia and correlates with phagocytosis by neutrophils during early pathogenesis","volume":"33","author":"Q Xu","year":"2015","journal-title":"Vaccine"},{"key":"pone.0277304.ref030","doi-asserted-by":"crossref","first-page":"100049","DOI":"10.1016\/j.jvacx.2019.100049","article-title":"Early pneumococcal clearance in mice induced by systemic immunization with recombinant BCG PspA-PdT prime and protein boost correlates with cellular and humoral immune response in bronchoalveolar fluids (BALF).","volume":"4","author":"C Goulart","year":"2020","journal-title":"Vaccine X"},{"issue":"2","key":"pone.0277304.ref031","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1086\/514062","article-title":"Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia","volume":"176","author":"T van der Poll","year":"1997","journal-title":"J Infect Dis"},{"issue":"3","key":"pone.0277304.ref032","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/mi.2014.95","article-title":"Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses","volume":"8","author":"R Wilson","year":"2015","journal-title":"Mucosal Immunol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0277304","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T18:40:52Z","timestamp":1670438452000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0277304"}},"subtitle":[],"editor":[{"given":"Ray","family":"Borrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,12,7]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0277304","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,7]]}}}